Science & Enterprise subscription

Follow us on Twitter

  • Our #podcast is now live ... NPC Members Display Photos At Annual Club Exhibit https://t.co/EsClVw9ZNc @pressclubdc #NPCPhotoEx
    about 1 day ago
  • More Democrats say they're in favor of increased federal spending on scientific research than Republicans, a gap th… https://t.co/SQBna2FykD
    about 1 day ago
  • New post on Science and Enterprise: Infographic – Partisan Split Remains on Research Spending https://t.co/FabPa5ufSb #Science #Business
    about 1 day ago
  • The first participant in a clinical trial received an experimental minimally-invasive brain implant to record brain… https://t.co/nPUNY6S2a5
    about 2 days ago
  • New post on Science and Enterprise: Trial Underway Testing Brain-Computer Implant https://t.co/olPDnbtfnW #Science #Business
    about 2 days ago

Please share Science & Enterprise

Gel, Crispr Help Defeat Cancer Drug Obstacles

Crispr-Cas9 illustration

A high-powered binding protein, formulated as a gel and targeted by Crispr gene editing is shown in lab mice to precisely deliver drugs and kill cancer cells. . . . → Read More: Gel, Crispr Help Defeat Cancer Drug Obstacles

Gene-Editing Biotech Gains $34M in Early Funds

Sickle cell illustration

A two year-old enterprise spun-off from Yale University is developing gene-editing treatments for genetic disorders with synthetic peptides and DNA delivered in nanoscale particles. . . . → Read More: Gene-Editing Biotech Gains $34M in Early Funds

Response by Patients Shown to Precision Lung Cancer Drug

Lung cancer illustration

Results of a clinical trial show a treatment targeting specific genetic aberrations produces a therapeutic response in most patients with lung cancer from that condition. . . . → Read More: Response by Patients Shown to Precision Lung Cancer Drug

Spin-Off Licensing Athletic Microbiome Technology

Runners

A company spun-off from biomedical engineering labs at Harvard University is acquiring research on microbial communities in elite athletes to create new probiotics. . . . → Read More: Spin-Off Licensing Athletic Microbiome Technology

Companies Call for Genome Editing Regulations

Crispr genome edits illustration

A group of companies developing treatments for disease using genome editing are calling for regulations and standards to govern these technologies in regenerative medicine. . . . → Read More: Companies Call for Genome Editing Regulations

Crispr Deployed for Programmable Smart Hydrogels

Crispr hydrogel

Bio-engineers developed a process using the gene editing technique Crispr to design gel materials with properties added for drug delivery, diagnostics, and electronic circuits. . . . → Read More: Crispr Deployed for Programmable Smart Hydrogels

Hispanic Neuro Disease Landscape Mapped in New Study

Brittany Dugger

A new project examines brain pathologies leading to development of Alzheimer’s disease in Americans of Hispanic descent, a group largely ignored in neuroscience. . . . → Read More: Hispanic Neuro Disease Landscape Mapped in New Study

Controlled Brain Tumor Gene Therapy Shown Safe

Brain tumor graphic

A clinical trial shows an experimental gene therapy that controls release of a powerful anti-tumor protein is safe for patients with stubborn glioblastoma, a type of brain cancer. . . . → Read More: Controlled Brain Tumor Gene Therapy Shown Safe

Engineered Bacteria Hydrogels Designed for Gut Repair

Nanofibers from engineered E. coli

Biomedical engineers genetically altered bacteria that when added to gel materials can be applied like a spray or ointment to help heal intestinal surfaces. . . . → Read More: Engineered Bacteria Hydrogels Designed for Gut Repair

FDA Investigating Data Manipulation in Gene Therapy Approval

Magnify facts

The Food and Drug Administration is investigating manipulation of preclinical tests submitted for its approval of a gene therapy to treat a rare disease. . . . → Read More: FDA Investigating Data Manipulation in Gene Therapy Approval